Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease
Authors:
- Jean-Philippe ColletJCJean-Philippe Collet
- Marco RoffiMRMarco Roffi
- Robert A ByrneRBRobert A Byrne
- Francesco CostaFCFrancesco Costa
- Marco ValgimigliMVMarco Valgimigli
- Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC)T(Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC)
- Héctor BuenoHBHéctor Bueno
- Anders JeppssonAJAnders Jeppsson
- Peter JüniPJPeter Jüni
- Adnan KastratiAKAdnan Kastrati
- Philippe KolhPKPhilippe Kolh
- Laura MauriLMLaura Mauri
Open Access
- 26 August 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 39 (3) , e1-e33
Abstract
The Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)Keywords
This publication has 69 references indexed in Scilit:
- Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary InterventionJACC, 2013
- Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry studyThe Lancet, 2013
- Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary interventionEuropean Heart Journal, 2013
- Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary StentingNew England Journal of Medicine, 2012
- Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary StentsCirculation, 2012
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug CoatingsCirculation, 2011
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor CoadministrationJACC, 2010
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Angiographic Follow-up after Placement of a Self-Expanding Coronary-Artery StentNew England Journal of Medicine, 1991